Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
Program strategy and prioritization supports projection of available capital through 2021BASKING RIDGE, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Caladrius...
News
BioCardia Anticipates DSMB Feedback on Interim Data From Pivotal Phase 3 CardiAMP Heart Failure Trial
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announces that it anticipates...
X4 Pharmaceuticals Appoints Diego Cadavid, M.D., as Chief Medical Officer
BOSTON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Calibre Scientific Enters the Canadian Market and Expands Product Portfolio With the Acquisition of Canadian Life Science
LOS ANGELES, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Canadian Life Science (“CLS”), a...
Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore™ for COVID-19 Immune Monitoring Service
Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via...
CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
-Funding from the Bill & Melinda Gates Foundation will support research to enable CRISPR/Cas9-based therapies for HIV that can benefit...
Reflect Scientific Inc. Adds Another Low Temperature Refrigeration Patent Solution to its Growing Intellectual Property Portfolio, and Business Update
OREM, Utah, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads
Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II &...
HEXO Corp Reports First Quarter Fiscal 2021 Financial Results
Record Quarter with Gross Revenue of $41.3 MillionAdjusted EBITDA Improves for the Sixth Consecutive Quarter OTTAWA, Dec. 14, 2020 (GLOBE...
Oncorus Appoints Scott Canute to its Board of Directors
-- Former Genzyme and Lilly executive brings broad industry expertise as Oncorus advances its viral immunotherapies pipeline and plans strategic...
Allarity Therapeutics Expands its Stenoparib License Rights to Include Anti-Viral Uses
Press Release Hørsholm, Denmark (14 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that...
Dr. Bobbi Peterson Overcomes Cancer, Bouncing Back With ThirstRX and a New YouTube Channel
Dr. Bobbi Peterson has not let being diagnosed with cancer hold her back. The celebrity doctor launches ThristRX and documents...
TG Therapeutics Announces Proposed Public Offering of Common Stock
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines...
AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
Cytokinetics Announces Data and Trial Design Presented at the International Symposium on ALS/MND
Additional Data from FORTITUDE-ALS Support Rationale and Design for COURAGE-ALS, A Planned Phase 3 Clinical Trial of Reldesemtiv in Patients with...
Athira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors
SEATTLE, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Cerevel Therapeutics to Host Inaugural Virtual R&D Event
Event will focus on CVL-865, the Phase 2 GABA Positive Allosteric Modulator, and include an overview of key preclinical programs...
Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO
PRESS RELEASE Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Further expansion of Ergomed’s presence in the...
Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
– ARV-471 demonstrates evidence of anti-tumor activity, and potential for best-in-class safety, and estrogen receptor (ER) degradation profile and robust...
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel...